The official blog of the Lung Institute.
With cellular research for COPD, hope is here.
The history of chronic obstructive pulmonary disease (COPD) is a long one. With chronic bronchitis having been recognized in the early 1800s, few achievements have been made outside of symptom relief with treatment typically taking the form of supplemental oxygen, inhalers and corticosteroids. However, since the 1950s the field of regenerative medicine—and by extension cellular therapy–has been steadily improving, with a dramatic increase in research for the use of cellular therapy for COPD. For many who suffer from COPD with few options, it seems hope may have arrived.
With your health in mind, the Lung Institute is here to break down Cellular Research for COPD: Hope Within a Golden Age of Advancement.
History of Cellular Research for COPD
From humble beginnings, the use of adult cellular therapy for the treatment of disease has been around since the early 1950s. Having once been called a bone marrow “transplant,” bone-marrow derived cells were once used to treat diseases of the blood such as leukemia. In the decades that followed, our understanding of cellular therapy was slow but gradual. It wasn’t until research was opened on embryonic cells that advancements within the field have led to a greater understanding of the body’s natural healing process, and the inherent potential of adult cells, which are derived from the patient’s body.
How Cellular Therapy Effects COPD
Cellular therapy for COPD has shown the potential to be effective in restoring quality of life and pulmonary function. As an alternative treatment option, cellular therapy uses the body’s natural healing mechanisms (cells) to promote internal repair. When introduced into the body of patients with chronic lung disease, cellular therapy has shown the ability to reduce inflammation and ease breathing. The benefit of cellular therapy particularly in comparison to more traditional forms of treatment (inhalers, corticosteroids and oxygen therapy) is that cellular therapy works to address not only symptoms but disease progression as whole.
What the Future Holds in Cellular Research for COPD
As the field of cellular research for COPD continues to be explored and studied, other uses for the biological discovery have quickly followed. Today, cells are being use for a variety of purposes, from helping people walk again to fixing broken hearts, the field of regenerative medicine has been rapidly growing as the potential of cellular therapy continues to be discovered. As new discoveries and applications for cellular therapy are being found every day, this is an exciting time in the medical field. As the scientific community continues to put their best minds to the task of solving the problems and complications of the human body, they serve as pioneers for the betterment of us all.
It’s important to consider any and all options on the path to better health. Although COPD can seem insurmountable, the first step to living a longer life is finding a treatment that addresses the disease head-on. Changing one’s diet and consistently exercising are among the best lifestyle changes one can do aside from quitting smoking. However, if you’re looking to address COPD progression directly, it may be time to consider cellular therapy. Rather than only addressing the symptoms of lung disease, cellular therapy directly affects disease progression and can improve quality of life and pulmonary function. For people with lung disease, a change in quality of life could mean the difference between struggling to walk to the mailbox and riding a bike.
If you or a loved one suffers from a chronic disease like ILD, COPD, pulmonary fibrosis or other symptoms of lung disease, the Lung Institute may be able to help with a variety of adult cellular therapy options. Contact us today at 888-745-6697 to see if you qualify for cellular therapy, and find out what cellular therapy could mean for you.
Interested in our article on Cellular Research for COPD: Hope Within a Golden Age of Advancement? Share your thoughts and comments below.